Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention.

BACKGROUND Blood transfusion has been associated with an increased mortality in patients undergoing percutaneous coronary intervention (PCI). Although the reasons for this remain unclear, it may be related to the structural and functional changes occurring within red blood cells (RBCs) during storage. We investigated whether RBC storage duration was associated with mortality in patients requiring transfusion after PCI. METHODS We collected data on all RBC transfusions occurring within 10 days of PCI (excluding those related to cardiac surgery) using the British Columbia Cardiac Registry and Central Transfusion Registry. Transfusion details were analyzed according to 30-day survival. RESULTS From a total of 32,580 patients undergoing PCI, 909 (2.8%) patients received RBCs with a mean storage duration of 25 +/- 10 days. In these 909 patients, mean transfusion volumes were lower in survivors (2.8 +/- 2.1 vs 3.8 +/- 2.9 U, P = .002) than those who died within 30 days. In a multivariate analysis to adjust for baseline risk, mean RBC storage age (HR 1.02 [95% CI 1.01-1.04], P = .002) and transfusion volume (HR 1.26 [95% CI 1.18-1.34], P < .001) both predicted 30-day mortality. Transfused patients who received only older blood (RBC min age >28 days) appeared to be at greater risk of death (HR 2.49 [95% CI 1.45-4.25], P = .001). CONCLUSION Red blood cell transfusion is associated with increased 30-day mortality in patients undergoing PCI. Although current transfusion practice permits RBC storage for up to 42 days, the use of older red cells may pose an additional hazard to this patient group.

[1]  M. Stafford-Smith,et al.  The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. , 2006, Anesthesia and analgesia.

[2]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[3]  N. Roubinian,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.

[4]  P. Poole‐Wilson,et al.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial , 2005, The Lancet.

[5]  E. Vamvakas,et al.  Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells , 1999, Transfusion.

[6]  D. Fergusson,et al.  Clinical consequences of red cell storage in the critically ill , 2006, Transfusion.

[7]  A. Brand,et al.  Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients , 2006, Transfusion.

[8]  J. Boura,et al.  Impact of Acute Blood Loss Anemia and Red Blood Cell Transfusion on Mortality after Percutaneous Coronary Intervention , 2007, Clinical cardiology.

[9]  W. Sibbald,et al.  Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. , 1997, American journal of respiratory and critical care medicine.

[10]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[11]  Eric Fretz,et al.  Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). , 2009, The American journal of cardiology.

[12]  T. Mihaljevic,et al.  Duration of red-cell storage and complications after cardiac surgery. , 2008, The New England journal of medicine.

[13]  M. Tweeddale,et al.  Association of mortality with age of blood transfused in septic ICU patients , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  J. Stamler,et al.  S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood , 2007, Proceedings of the National Academy of Sciences.

[15]  L. Wolfe.  The membrane and the lesions of storage in preserved red cells , 1985, Transfusion.

[16]  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007 .

[17]  D. Holmes,et al.  Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. , 2009, Journal of the American College of Cardiology.

[18]  M. Remberger,et al.  Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction , 1997, Transfusion.

[19]  I. T. Demchenko,et al.  Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. , 1997, Science.

[20]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[21]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[22]  C. Yap,et al.  Age of transfused red cells and early outcomes after cardiac surgery. , 2008, The Annals of thoracic surgery.

[23]  R. Califf,et al.  Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[24]  J D Hilton,et al.  Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[25]  Sunil V. Rao,et al.  Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[26]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[27]  J. Marshall,et al.  Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.

[28]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[29]  Robert M Califf,et al.  Evolution of adverse changes in stored RBCs , 2007, Proceedings of the National Academy of Sciences.

[30]  J. Stamler,et al.  Nitric oxide in the human respiratory cycle , 2002, Nature Medicine.